69 patents
Page 4 of 4
Utility
Progesterone Formulations Having a Desirable PK Profile
18 Dec 19
This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters.
Julia AMADIO, Brian Bernick, Peter H.R. Persicaner
Filed: 11 Feb 19
Utility
Vaginal Inserted Estradiol Pharmaceutical Compositions and Methods
27 Nov 19
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
Sebastian Mirkin, Julia M. Amadio, Brian Bernick
Filed: 6 Dec 16
Utility
Vaginal Inserted Estradiol Pharmaceutical Compositions and Methods
13 Nov 19
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
Sebastian Mirkin, Julia M. Amadio, Brian A. Bernick
Filed: 8 May 18
Utility
Natural combination hormone replacement formulations and therapies
13 Nov 19
Estrogen and progesterone replacement therapies are provided herein.
Brian A. Bernick, Janice Louise Cacace, Peter H.R. Persicaner, Neda Irani, Julia M. Amadio
Filed: 22 Jul 19
Utility
Vaginal inserted estradiol pharmaceutical compositions and methods
11 Nov 19
In one aspect, pharmaceutical compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided.
Brian A. Bernick, Peter H. R. Persicaner, Janice Louise Cacace, Neda Irani, Julia M. Amadio
Filed: 8 Feb 18
Utility
Steroid hormone pharmaceutical composition
11 Nov 19
This disclosure provides a novel pharmaceutical composition for delivering steroid hormones to a patient in need thereof.
Annette Shadiack, Peter H. R. Persicaner, Philip B. Inskeep, Thorsteinn Thorsteinsson, Frederick D. Sancilio, Jason D. Legassie
Filed: 20 Feb 18
Utility
Progesterone formulations having a desirable PK profile
11 Nov 19
This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters.
Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick
Filed: 8 Mar 17
Utility
Formulations for Solubilizing Hormones
23 Oct 19
Compositions and methods for the solubilization of steroid hormones are disclosed.
Thorsteinn THORSTEINSSON, Frederick D. Sancilio
Filed: 1 May 19
Utility
Natural Combination Hormone Replacement Formulations and Therapies
16 Oct 19
Pharmaceutical compositions for co-administering estradiol and progesterone to a human subject in need thereof are provided.
Brian A. Bernick, Peter H.R. Persicaner, Julia M. Amadio
Filed: 8 Jan 19